S100A8 and cardiac hypertrophy: While typically low in cardiomyocytes, S100A8 expression increases in response to thyroid hormone treatment in neonatal rat cardiomyocytes (71), contributing to cardiac hypertrophy via the MyD88/NF-κB pathway (72).